Cord blood stem cells for diabetic kidney disease
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether injecting stem cells from donated umbilical cords can help people with kidney damage caused by type 2 diabetes. The goal is to see if this treatment can slow the decline in kidney function and safely improve their condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes for at least 5 years.
- You are between 30 and 70 years old (no age limit if a kidney biopsy confirmed diabetic kidney disease).
- Your kidney function is moderately to severely reduced, with a measure called eGFR between 15 and 60.
- For the past 3 months, you have been on blood pressure medicine (ACE inhibitors or ARBs) and your blood pressure is controlled (≤150/100).
- You have been on a stable dose of certain diabetes drugs (like empagliflozin, dapagliflozin, or others) for at least 3 months and continue the same dose during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new system to manage diabetic kidney disease across all stages. It is for people with type 2 diabetes who either have no kidney damage or have kidney damage confirmed by a biopsy.
This trial tests whether stem cells from donated umbilical cords can safely help people with type 2 diabetes who also have kidney damage. It aims to see if this therapy can improve kidney function.
This trial tests whether infusing stem cells from umbilical cord blood can help slow kidney damage caused by type 2 diabetes. You would receive the stem cells through an IV, and researchers will monitor your kidney function over time.
This trial tests whether a type of stem cell therapy can help people with chronic kidney disease caused by diabetes or high blood pressure. It may slow down kidney damage and improve kidney function.
This trial tests whether a type of stem cell called mesenchymal stromal cells (Amimestrocel) can help people with diabetic kidney disease. It aims to see if the treatment is safe and can improve kidney function.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
Hear when a new Diabetic Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.